APRIL is increased in serum of patients with brain glioblastoma multiforme

European Cytokine Network

Volumn 17, Issue 4, 2006, Pages 276-280

  Iłzecka, Joanna ^a   Iłzecki, Marek ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

APRIL; Cytokine; Glioblastoma multiforme; Serum; Tumor

Indexed keywords

APRIL PROTEIN; C REACTIVE PROTEIN;

ARTICLE; BLOOD; BRAIN TUMOR; CASE CONTROL STUDY; FEMALE; GLIOBLASTOMA; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

BRAIN NEOPLASMS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 34249987749     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Medema JP, Planelles-Carazo L, et al. The uncertain glory of APRIL. Cell Death Differ 2003; 10: 1121.
2. Lopez-Fraga M, Fernandez R, Albar JP, et al. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep 2001; 2: 945.
3. Ng LG, Mackay CR, Mackay F. The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 2005; 42: 763.
4. Zhang M, Ko KH, Lam QL, et al. Novel function of TNF cytokines in regulating bone marrow B cell survival. Cell Mol Immunol 2004; 1: 447.
5. Wallweber HJ, Compaan DM, Starovasnik MA, et al. The crystal structure of a proliferation-inducing ligand, APRIL. J Mol Biol 2004; 343: 283.
6. Hahne M, Kataoka T, Schroter M, et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 1998; 188: 1185.
7. Kelly K, Manos E, Jensen G, et al. APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res 2000; 60: 1021.
8. Thangarajh M, Masterman T, Rot U, et al. Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis. J Neuroimmunol 2005; 167: 210.
9. Seyler TM, Park YW, Takemura S, et al. BlyS and APRIL in rheumatoid arthritis. J Clin Invest 2005; 115: 3083.
10. Jonsson MV, Szodoray P, Jellestad S, et al. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome. J Clin Immunol 2005; 25: 189.
11. Koyama T, Tsukamoto H, Miyagi Y, et al. Raised serum APRIL levles in patients with systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 1065.
12. Stohl W, Metyas S, Tan SM, et al. Inverse association between cirulating APRIL levels and serological and clinical disease activity in patients with lupus erythematosus. Ann Rheum Dis 2004; 63: 1096.
13. Roth W, Waquenknecht B, Klumpp A, et al. APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis. Cell Death Differ 2001; 8: 403.
14. Deshayes F, Lapree G, Portier A, et al. Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via specific receptor. Oncogene 2004; 23: 3005.